Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Preferred Shares: 2017

  • Rocket Pharmaceuticals' Preferred Shares was N/A to $25.4 million in Q4 2017 from the same period last year, while for Dec 2017 it was $25.4 million, marking a year-over-year change of. This contributed to the annual value of $25.4 million for FY2017, which is N/A change from last year.
  • Latest data reveals that Rocket Pharmaceuticals reported Preferred Shares of $25.4 million as of Q4 2017.
  • Rocket Pharmaceuticals' Preferred Shares' 5-year high stood at $25.4 million during Q4 2017, with a 5-year trough of $25.4 million in Q4 2017.
  • Its 1-year average for Preferred Shares is $25.4 million, with a median of $25.4 million in 2017.